Shockwave Medical Stock News

Buyout rumors have been swirling around this mid-cap medtech company this week.

Buyout rumors have been swirling around this mid-cap medtech company this week.

Shockwave Medical (SWAV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in

Shockwave Medical (SWAV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in

Abbott (ABT), Boston Scientific (BSX) and Medtronic (MDT) are the most likely potential buyers of ShockWave Medical (SWAV) after a report late Friday that the company has received…

Penumbra Inc (NYSE: PEN) is exploring a potential deal with Shockwave Medical Inc (NASDAQ: SWAV), Bloomberg reported citing people with knowledge of the matter. According to the people, Penumbra

SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex

ShockWave Medical, Inc. (NASDAQ:SWAV)s share price gapped down prior to trading on Friday after an insider sold shares in the company. The stock had previously closed at $180.59, but opened at $166.49. ShockWave Medical shares last traded at $163.43, with a volume of 219 shares trading hands. Specifically, Director Frank T. Watkins sold 2,008 shares []

Wells Fargo & Company upgraded shares of ShockWave Medical (NASDAQ:SWAV) from an equal weight rating to an overweight rating in a research note released on Monday, PriceTargets.com reports. They currently have $235.00 target price on the stock. Several other equities analysts have also recently issued reports on SWAV. SVB Leerink boosted their target price on [] The post ShockWave Medical (NASDAQ:SWAV) Lifted to Overweight at Wells Fargo & Company appeared first on ETF Daily News .

Wells Fargo & Company upgraded shares of ShockWave Medical (NASDAQ:SWAV) from an equal weight rating to an overweight rating in a research note published on Monday, PriceTargets.com reports. They currently have $235.00 price target on the stock. A number of other research analysts have also commented on the stock. Zacks Investment Research lowered shares of []

ShockWave Medical (NASDAQ:SWAV) and Apollo Endosurgery (NASDAQ:APEN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability. Institutional & Insider Ownership 91.4% of ShockWave Medical shares are held by institutional investors. Comparatively, 64.7% []

Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical Limb Ischemia Global Post-Market Study Will Assess